GSK3A and Alzheimer disease: Unexpectedly, our combined analysis also uncovered evidence of decreased kinases associated with tau phosphorylation (including GSK3A, GSK3B, CDK5, MARK1 and ROCK2), despite the increased phosphorylation of tau in AD (Supplementary Data 3).